Your browser doesn't support javascript.
A review of Ciclesonide in COVID-19. Still a long way to go.
Deokar, Kunal; Agarwal, Mehul; Dutt, Naveen; Chauhan, Nishant; Niwas, Ram; Shadrach, Benhur Joel; Chawla, Gopal.
  • Deokar K; Pulmonary, Critical Care & Sleep Medicine, Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India. dkunal@live.in.
  • Agarwal M; Pulmonary, Critical Care & Sleep Medicine, Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
  • Dutt N; Pulmonary, Critical Care & Sleep Medicine, Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
  • Chauhan N; Pulmonary, Critical Care & Sleep Medicine, Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
  • Niwas R; Pulmonary, Critical Care & Sleep Medicine, Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
  • Shadrach BJ; Pulmonary, Critical Care & Sleep Medicine, Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
  • Chawla G; Pulmonary, Critical Care & Sleep Medicine, Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
Adv Respir Med ; 89(1): 79-81, 2021.
Article in English | MEDLINE | ID: covidwho-1143738
ABSTRACT
As no definitive therapy or vaccine is yet available for COVID-19, in a desperate attempt repurposed drugs are being explored as an option. A drug repurposing study identified Ciclesonide as a potential candidate. We reviewed the available evidence and clinical trials on the use of Ciclesonide in COVID-19. At present the evidence is limited to a report of three cases. However, five clinical trials are underway, and their results will help in elucidating the role of Ciclesonide in COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnenediones / Drug Repositioning / COVID-19 Drug Treatment / Glucocorticoids Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Female / Humans / Male Language: English Journal: Adv Respir Med Year: 2021 Document Type: Article Affiliation country: ARM.a2020.0173

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnenediones / Drug Repositioning / COVID-19 Drug Treatment / Glucocorticoids Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Female / Humans / Male Language: English Journal: Adv Respir Med Year: 2021 Document Type: Article Affiliation country: ARM.a2020.0173